Therefore, TRIM69 may serve as a marker of COAD and provide an adjuvant mechanism to enhance the effectiveness of various anti-cancer chemotherapeutic agents, such as 5-fluorouracil and programmed cell death protein 1 (PD-1) inhibitors. This evidence concerns the gene PDCD1 and colon adenocarcinoma.